protein
produc
bodi
control
mediat
metabol
process
help
routin
function
kind
impair
protein
product
product
mutat
protein
misfold
protein
lead
disrupt
pathway
control
protein
may
manifest
form
diseas
howev
diseas
treat
suppli
protein
outsid
exogen
suppli
activ
exogen
protein
requir
product
larg
scale
fulfi
grow
demand
process
complex
requir
higher
protein
express
purifi
cation
process
product
need
uniqu
set
standard
largescal
product
purifi
cation
largescal
product
fulfi
grow
demand
thu
need
costeffect
tool
genet
engin
util
produc
protein
human
origin
bacteria
fungi
insect
mammalian
host
usag
recombin
dna
technolog
largescal
product
protein
requir
ampl
amount
time
labor
resourc
also
offer
mani
opportun
econom
growth
read
chapter
reader
would
abl
understand
basic
product
recombin
protein
variou
host
along
advantag
limit
host
system
properti
product
import
pharmaceut
compound
growth
factor
protein
produc
bodi
control
mediat
metabol
process
help
routin
function
kind
impair
protein
product
product
mutat
protein
misfold
protein
lead
disrupt
pathway
control
protein
may
manifest
form
diseas
howev
diseas
treat
suppli
protein
outsid
exogen
suppli
activ
exogen
protein
requir
product
larg
scale
fulfi
grow
demand
process
complex
requir
higher
protein
express
purifi
cation
process
product
need
uniqu
set
standard
largescal
product
purifi
cation
largescal
product
fulfi
grow
demand
thu
need
costeffect
tool
genet
engin
util
produc
protein
human
origin
bacteria
fungi
insect
mammalian
host
fig
usag
recombin
dna
technolog
largescal
product
protein
requir
ampl
amount
time
labor
resourc
also
offer
mani
opportun
econom
growth
read
chapter
reader
would
abl
understand
basic
product
recombin
protein
variou
host
along
advantag
limit
host
system
properti
product
import
pharmaceut
compound
growth
factor
live
cell
express
gene
occur
genet
inform
contain
dna
pass
rna
process
transcript
rna
protein
process
translat
thu
bodi
synthes
rna
protein
accord
instruct
dna
dnadepend
rna
polymeras
rna
polymeras
carri
transcript
eukaryot
three
rna
polymeras
polymeras
transcrib
ribosom
rna
gene
polymeras
ii
transcrib
proteincod
gene
mrna
small
rna
polymeras
iii
transcrib
gene
trna
prokaryot
cell
e
coli
rna
polymeras
consist
fi
subunitstwo
ident
subunit
one
subunit
subunit
subunit
dissoci
polymer
ensu
thu
term
holoenzym
use
complet
enzym
core
enzym
use
without
subunit
process
transcript
initi
bind
rna
polymeras
dna
molecul
specifi
c
site
call
promot
promot
critic
start
transcript
promot
site
nearli
bp
long
mostli
locat
fi
rst
base
copi
rna
fig
fi
rst
base
call
start
point
transcript
denot
promot
rnapol
ii
allow
differenti
express
gene
determin
rate
gene
transcrib
express
clone
gene
gene
essenti
regulatori
element
requir
transcript
gene
gene
attach
select
gene
help
select
clone
gene
interest
cell
screen
synthesi
desir
product
process
largescal
product
bioreactor
optimum
condit
high
yield
promot
caus
insert
gene
express
time
part
system
known
constitut
promot
other
allow
express
certain
stage
certain
tissueorgan
individu
certain
time
point
gene
express
tempor
spatial
regul
prokaryot
posit
start
site
interact
subunit
holoenzym
rna
polymeras
eukaryot
sequenc
analog
sequenc
prokaryot
tataaaa
present
posit
promot
region
eukaryot
promot
shown
fig
tata
box
form
core
promot
posit
upstream
transcript
start
site
caat
box
gc
box
approxim
respect
locat
promot
alway
dna
molecul
regul
refer
cisact
element
space
variou
element
import
much
depend
locusspecifi
c
activ
either
core
promot
distant
site
variou
signal
enhanc
also
involv
far
apart
target
gene
exert
stimulatori
effect
promot
activ
upstream
downstream
middl
gene
promot
housekeep
gene
gene
complex
pattern
express
cpg
island
rather
tata
box
gene
transcrib
region
utr
exon
code
region
separ
intron
noncod
region
end
region
utr
clone
gene
express
usual
intronless
version
gene
use
eukaryot
transcript
enhanc
enhanc
may
base
away
promot
region
abl
affect
rate
transcript
simplest
host
work
recombin
dna
technolog
prokaryot
bacteri
system
earli
fi
rst
recombin
fdaapprov
pharmaceut
human
insulin
humulinushumulineeu
obtain
genet
engin
escherichia
coli
e
coli
treatment
diabet
due
increas
demand
mani
strain
microbi
speci
design
increas
throughput
better
recoveri
therapeut
protein
largescal
cultur
recombin
protein
approv
fda
obtain
either
escherichia
coli
prokaryot
saccharomyc
cerevisia
fungal
speci
insect
cell
mammalian
cell
human
cell
transgen
plant
anim
clone
product
protein
particular
host
system
depend
upon
properti
host
clone
express
desir
size
proteinencod
gene
product
correctli
modifi
ed
fold
function
protein
high
yield
protein
lowcost
requir
choic
host
system
requir
best
system
fulfi
requir
advantag
produc
protein
use
recombin
dna
technolog
human
gene
may
clone
express
minim
risk
immun
reaction
specifi
c
activ
protein
high
therapeut
protein
produc
effici
maintain
costeffect
minim
risk
transmiss
unknown
pathogen
present
anim
human
sourc
appropri
modifi
cation
higher
specifi
citi
increas
halflif
improv
function
allow
creat
critic
chang
better
specifi
citi
activ
express
product
eukaryot
protein
requir
clone
cdna
express
vector
subsequ
transfer
vector
suitabl
host
dna
modifi
ed
clone
express
host
product
protein
thu
optimum
product
condit
requir
host
howev
yield
variat
differ
express
system
highlevel
express
protein
may
achiev
consid
follow
point
though
variou
host
system
avail
product
recombin
protein
microbi
host
offer
sever
advantag
system
product
fast
cheap
econom
molecular
biolog
physiolog
well
character
document
easi
maintain
manipul
util
inexpens
nutrit
sourc
rapid
growth
biomass
accumul
achiev
high
cell
densiti
scaleup
easi
conveni
express
machineri
varieti
strong
induc
promot
cellular
structur
bacteria
rapidli
adapt
cultur
condit
short
replic
time
min
media
requir
bacteri
cell
simpl
consist
simpl
carbon
nitrogen
sourc
thu
overal
input
bacteria
lower
mammalian
cell
induc
promot
may
requir
induc
deplet
addit
specifi
c
nutrient
ph
chang
chang
physicochem
factor
order
initi
process
gene
express
induc
system
suffer
disadvantag
chemic
induc
may
expens
toxic
would
requir
elimin
downstream
process
product
intend
human
usag
thu
usag
thermoregul
system
use
product
recombin
pharmaceut
protein
express
depend
upon
strong
heatregul
promot
minim
risk
addit
chemic
agent
approv
bacteriaderiv
either
european
union
fda
usa
therapeut
includ
hormon
human
insulin
insulin
analog
calcitonin
human
growth
hormon
glucagon
parathyroid
hormon
somatropin
insulinlik
growth
factor
interferon
interleukin
light
heavi
chain
rais
vascular
endotheli
growth
factora
tumor
necrosi
factor
alpha
cholera
b
subunit
protein
granulocyt
colonystimul
factor
plasminogen
activ
microb
fi
rst
choic
product
recombin
protein
enterobacterium
e
coli
system
offer
quick
easi
modifi
cation
eas
grow
manag
environment
condit
short
life
cycl
bacteri
cell
toler
adapt
chang
environ
rapidli
thu
scaleup
easier
howev
system
suffer
disadvantag
human
mammalian
gene
clone
bacteria
undergo
splice
due
lack
splice
machineri
thu
intronless
version
gene
clone
optimum
result
fig
signal
involv
transcript
gene
may
vari
thu
gene
interest
usual
fuse
bacteri
gene
control
promot
protein
obtain
fusion
product
later
cleav
purifi
ed
use
lac
promot
one
popular
bacteri
promot
howev
highlevel
express
promot
also
prefer
present
pet
vector
addit
amino
acid
process
translat
one
codon
sever
amino
acid
thu
codon
bias
occur
prefer
particular
codon
amino
acid
particular
speci
fig
complex
eukaryot
cell
advantag
produc
fulli
function
properli
fold
protein
antibodi
four
subunit
may
secret
eukaryot
cell
fulli
function
form
hand
diffi
cult
obtain
multidomain
protein
e
coli
even
protein
obtain
renatur
fold
laboratori
condit
may
either
expens
protein
may
lack
activ
lack
posttransl
modifi
cation
ptm
problem
solv
mandatori
activ
mani
therapeut
protein
glycosyl
common
modifi
cation
other
phosphoryl
format
disulfi
de
bond
essenti
requir
full
function
capabl
mani
human
protein
ptm
play
import
role
proper
protein
fold
process
stabil
tissu
target
activ
immun
reactiv
halflif
protein
lack
result
insolubl
unstabl
inact
product
howev
nlink
glycosyl
system
campylobact
jejuni
success
transfer
e
coli
thu
open
possibl
product
glycosyl
protein
certain
mutant
e
coli
develop
promot
disulfi
de
bond
format
origami
rosettagami
reduc
proteas
activ
overproduct
recombin
protein
bacteria
might
result
loss
solubl
deposit
mani
protein
speci
protein
aggreg
inclus
bodi
alter
growth
condit
might
render
product
insolubl
form
mani
eukaryot
protein
found
trap
inclus
bodi
resist
process
success
obtain
purifi
cation
insulin
betaferon
inclus
bodi
retriev
protein
use
denatur
condit
subsequ
refold
renatur
might
alway
easi
prove
extrem
expens
e
coli
host
diffi
cult
obtain
protein
larger
kda
solubl
form
due
certain
limit
product
protein
e
coli
host
system
discuss
product
protein
two
nacetylglucosamin
residu
core
may
attach
differ
oligosaccharid
form
differ
glycoprotein
man
glcnac
glcnac
asnpentasaccharid
core
glycosyl
one
import
posttransl
modifi
cation
occur
insid
lumen
endoplasm
reticulum
er
golgi
complex
er
golgi
complex
import
protein
target
transport
nlink
glycosyl
start
endoplasm
reticulum
continu
golgi
complex
polypeptid
synthes
ribosom
howev
olink
glycosyl
exclus
occur
golgi
complex
process
oligosaccharid
attach
protein
associ
special
lipid
present
er
dolichol
phosphat
consist
isopren
unit
phosphat
dolichol
phosphat
oligosaccharid
transfer
specifi
c
asparagin
residu
polypeptid
chain
ribosom
enzym
respons
glycosyl
protein
activ
oligosaccharid
locat
lumen
side
er
transport
golgi
complex
carbohydr
unit
alter
fi
naliz
golgi
complex
respons
olink
sugar
attach
modifi
cation
nlink
sugar
protein
target
transport
destin
coval
attach
carbohydr
group
protein
form
glycoprotein
call
glycosyl
glycoprotein
protein
constitut
major
fraction
play
import
role
variou
physiolog
process
compon
cell
membran
carbohydr
commonli
attach
protein
may
fucos
fuc
galactos
gal
nacetylgalactosamin
galnac
glucos
glc
nacetylglucosamin
glcnac
mannos
man
sialic
acid
sia
sugar
moieti
may
associ
amid
nitrogen
atom
side
chain
asparagin
asn
term
nlink
glycosyl
oxygen
atom
side
chain
serin
ser
threonin
thr
term
olink
glycosyl
asparagin
asn
present
polypeptid
accept
carbohydr
moieti
residu
sequenc
asnxser
asnxthr
x
amino
acid
except
prolin
target
glycosyl
residu
sequenc
aspect
structur
protein
cell
type
determin
glycosyl
site
nlink
sugar
residu
common
core
pentasaccharid
pentasaccharid
consist
three
mannos
continu
due
problem
encount
e
coli
product
larger
protein
modifi
ed
protein
next
costeffect
fast
highdens
easi
handl
system
fungi
saccharomyc
cerevisia
yeast
system
choic
diffi
cult
obtain
therapeut
protein
solubl
form
appropri
posttransl
modif
bacteri
host
yeast
mutant
avail
give
high
yield
approv
product
obtain
yeast
hormon
vaccin
recombin
granulocyt
macrophag
colonystimul
factor
gmcsf
albumin
hirudin
plateletderiv
growth
factor
pdgf
advantag
cerevisia
follow
secret
recombin
protein
cultur
protein
properli
fold
perform
posttransl
modifi
cation
yeast
system
high
amount
recombin
protein
obtain
yeast
also
capabl
perform
posttransl
modifi
cation
olink
glycosyl
phosphoryl
acetyl
acyl
differ
drastic
pattern
nlink
glycosyl
fig
chaperon
famili
highli
conserv
differ
protein
import
function
chaperon
prevent
aggreg
misfold
newli
synthes
polypeptid
chain
prevent
irrevers
aggreg
nonn
conform
maintain
protein
product
fold
pathway
prevent
nonproduct
interact
compon
cell
help
guid
direct
assembl
multisubunit
protein
complex
larger
protein
chaperon
involv
fold
recogn
nonn
substrat
protein
mainli
via
expos
hydrophob
residu
major
class
molecular
chaperon
heat
shock
protein
present
varieti
system
prevent
damag
protein
high
heat
continu
differ
nglycosyl
yeast
high
hypermannos
highli
immunogen
unmodifi
ed
protein
suitabl
product
yeast
member
fungi
pichia
pastori
pichia
methanolica
candida
boidinii
pichia
angusta
facult
methylotroph
yeast
great
potenti
pichia
pastori
favor
high
cell
densiti
obtain
protein
secret
high
concentr
gl
less
hypermannosyl
compar
yeast
thu
less
immunogen
howev
disadvantag
requir
methanol
induc
gene
express
transgen
control
promot
alcohol
oxidas
gene
methanol
may
fl
ammabl
toxic
cell
human
thoroughli
remov
hypermannosetyp
glycosyl
fungi
also
unsuit
product
mani
recombin
protein
insect
cell
insect
cell
infect
baculovirus
doublestrand
circular
dna
virus
arthropod
host
baculovirusmedi
gene
express
insect
method
choic
costeffect
give
much
higher
yield
recombin
protein
compar
system
possibl
produc
larg
protein
result
product
correctli
process
biolog
activ
protein
baculoviru
autographa
californica
nuclear
polyhedrosi
viru
acmnpv
use
clone
vector
insect
cell
line
viral
polyhedron
protein
use
requir
normal
habitat
exhibit
high
rate
transcrip
bacteri
chaperon
bind
partial
fold
misfold
protein
function
groel
requir
cofactor
groe
tetradecamer
mitochondri
chaperonin
implic
protein
import
macromolecular
assembl
requir
fold
precursor
polypeptid
atpdepend
manner
prevent
aggreg
mediat
refold
protein
heat
shock
central
compon
cellular
network
fold
catalyst
molecular
chaperon
assist
differ
type
process
protein
fold
cell
transient
associ
substrat
bind
domain
short
hydrophob
peptid
bind
releas
substrat
switch
lowaffi
niti
atpbound
state
highaffi
niti
adpbound
state
form
complex
network
fold
machin
highli
abund
chaperon
play
import
role
mani
cellular
process
exampl
cell
cycl
control
cell
surviv
hormon
signal
pathway
key
player
maintain
cellular
homeostasi
stress
atpas
activ
whose
bind
hydrolysi
affect
conform
dynam
protein
becom
major
therapeut
target
cancer
role
explor
neurodegen
disord
infecti
diseas
eukaryot
chaperonin
tailless
complex
polypeptid
ring
complex
tric
facilit
proper
fold
mani
cellular
protein
continu
tion
need
cell
cultur
thu
code
sequenc
gene
replac
foreign
dna
gene
transcrib
control
power
polyhedron
promot
high
yield
total
cell
protein
observ
yield
may
variabl
due
cours
viru
infect
viral
titer
product
recombin
protein
insect
cell
time
consum
compar
bacteri
system
cell
growth
slow
cost
medium
high
everi
time
fresh
cell
requir
viral
infect
lethal
cell
also
limit
perform
posttransl
modifi
cation
perform
nonsyal
nlink
glycosyl
optim
need
perfect
yield
depend
upon
viru
titer
time
taken
infect
express
insect
cell
prefer
activ
protein
diffi
cult
obtain
e
coli
system
genet
engin
use
select
invitrogen
transgen
cell
line
express
necessari
enzym
obtain
human
complex
nlink
glycosyl
pattern
system
extens
use
structur
studi
correctli
fold
eukaryot
protein
may
obtain
secret
form
simplifi
purifi
cation
protocol
approv
biopharmaceut
infect
insect
cell
line
hi
five
cervarix
recombin
papillomaviru
ctermin
truncat
major
capsid
protein
type
use
cancer
vaccin
glycosyl
problem
encount
insect
cell
use
product
recombin
human
glycosyl
protein
lot
genet
engin
requir
produc
humanlik
glycosyl
insect
cell
thu
prefer
system
therapeut
human
protein
product
mammalian
system
chines
hamster
ovari
cell
line
due
time
diffi
cultli
maintain
insect
cell
mammalian
cell
explor
product
recombin
protein
mammalian
cell
properti
protein
fold
assembl
posttransl
modifi
cation
becom
prefer
system
protein
product
account
major
recombin
protein
product
mammalian
cell
product
complex
protein
requir
extens
process
posttransl
modifi
cation
mammalian
cell
advantag
perform
ptm
fig
correctli
secret
recombin
protein
medium
natur
form
thu
skip
critic
step
renatur
refold
sometim
lead
inact
protein
therefor
major
therapeut
protein
produc
mammalian
cell
primarili
chines
hamster
ovari
cho
cell
babi
hamster
kidney
cell
bhk
cho
cell
rel
easi
manipul
properti
favor
largescal
product
protein
produc
safe
use
human
advers
reaction
similar
glycosyl
pattern
chines
hamster
ovari
cho
babi
hamster
kidney
bhk
cell
promin
produc
recombin
protein
fig
recombin
therapeut
product
use
clinic
applic
produc
mammalian
cell
mammalian
cell
maintain
serumbloodplasmabas
medium
therefor
presenc
infecti
agent
product
might
deleteri
properli
remov
infect
may
rang
hiv
coronaviru
sever
acut
respiratori
syndrom
sar
nonlipidenvelop
nle
virus
circovirus
torqu
tenoviru
ttv
torqu
tenominiviru
ttmv
hbv
hcv
htlv
human
tcell
lymphotrop
viru
west
nile
viru
prion
selfrepl
infecti
protein
may
also
present
may
lead
variant
creutzfeldtjakob
diseas
vcjd
pathogen
transmiss
major
concern
manufactur
bloodderiv
coagul
factor
earli
factor
replac
product
deriv
plasma
use
treat
hemophilia
found
contamin
hiv
hbv
hcv
virus
year
usbas
hemophil
patient
infect
hiv
infect
hcv
parvovirus
present
conin
mammalian
cell
gene
express
either
transient
stabli
obtain
stabli
transform
cell
line
requir
usag
select
marker
anoth
major
advantag
cell
grown
suspens
serumfre
sf
proteinfre
chemic
defi
ned
media
product
safe
without
risk
prion
bovin
spongiform
encephalopathi
bse
bovin
serum
albumin
infect
variant
creutzfeldtjakob
diseas
vcjd
human
serum
present
due
viru
prion
donor
plasma
blood
sampl
manufactur
opt
plasmaserumfre
growth
medium
cultur
cell
line
cell
requir
compon
albumin
transfer
growth
nowaday
recombin
human
albumin
avail
like
human
insulin
produc
e
coli
yeast
yeastderiv
animalfre
recombin
human
transferrin
avail
support
plasmafre
mammalian
cell
cultur
els
cho
cell
may
engin
produc
transfer
insulinlik
growth
factor
therapeut
protein
obtain
mammalian
cell
treat
test
presenc
pathogen
agent
virus
contamin
therapeut
product
obtain
process
treat
variou
agent
remov
inact
viru
presenc
asymptomat
viru
pose
seriou
risk
common
viru
inactiv
techniqu
use
solvent
deterg
effect
lipidenvelop
virus
human
immunodefici
viru
hiv
hepat
b
c
viru
hbv
hcv
human
tcell
lymphotrop
viru
htlv
west
nile
viru
wnv
nonlipidenvelop
virus
parvovirus
enterovirus
circovirus
resist
inactiv
via
solvent
deterg
treatment
human
herpesviru
respons
kaposi
sarcoma
shown
transmit
blood
blood
product
follow
outbreak
strict
requir
impos
manufactur
biolog
medic
devic
concern
prompt
manufactur
switch
sugarbas
fi
nal
formul
develop
recombin
plasmafre
albumin
produc
yeast
usag
biopharmaceut
manufactur
plasmafre
manufactur
involv
elimin
plasma
deriv
everi
step
like
cell
line
develop
upstream
process
downstream
process
fi
nal
formul
process
appropri
postproduct
check
manufactur
shift
use
serum
serumfre
cell
cultur
media
anim
productfre
media
ultim
proteinfre
complet
synthet
chemic
defi
ned
media
media
consist
protein
hydrolys
deriv
yeast
soy
wheat
amino
acid
peptid
carbohydr
vitamin
essenti
element
ultrafi
ltere
remov
unwant
contamin
continu
replagalalfagalactosidas
lysosom
hydrolas
approv
european
union
eu
food
drug
administr
fda
usa
product
fulli
glycosyl
express
human
cell
line
use
therapeut
human
be
transgen
protein
product
transgen
anim
success
use
product
recombin
protein
detail
refer
chap
protein
product
pose
great
risk
term
safeti
transmiss
infecti
agent
allerg
respons
immun
reactiv
autoimmun
respons
might
occur
atryn
approv
approv
european
medic
agenc
fda
recombin
biopharmaceut
use
transgen
anim
contain
human
antithrombin
glycosyl
moieti
secret
milk
transgen
goat
rhucin
intend
acut
attack
angioedema
patient
congenit
inhibitor
activ
defi
cienci
obtain
transgen
rabbit
deni
approv
transgen
plant
explor
recombin
protein
produc
research
diagnost
use
obtain
therapeut
protein
natur
sourc
pose
threat
spread
diseas
therefor
altern
system
product
therapeut
agent
benefi
ts
molecular
farm
plant
wide
explor
product
recombin
pharmaceut
protein
advantag
low
cost
high
mass
product
scaleup
lack
human
pathogen
addit
eukaryot
ptm
fi
rst
recombin
protein
obtain
tobacco
plant
human
growth
hormon
howev
sometim
plantspecifi
c
ptm
might
result
advers
immun
reactiv
product
recombin
heterolog
protein
plant
simpl
use
product
nonnatur
occur
protein
singl
chain
fv
fragment
scfv
high
yield
recombin
protein
main
goal
product
system
transgen
plant
therefor
appropri
express
vector
construct
design
achiev
high
yield
engin
gene
product
tamin
plasmaderiv
factor
viii
therefor
product
urgent
requir
regulatori
measur
came
fi
rst
recombin
factor
viii
advat
baxter
usa
advat
produc
cho
cell
grown
serumfre
proteinfre
medium
ultrafi
ltere
soybean
peptid
subsequ
purifi
cation
immunoaffi
niti
chromatographi
usag
advat
help
elimin
risk
transmit
emerg
blood
pathogen
prion
pose
seriou
risk
highli
resist
physicalchem
inactiv
earli
stage
prion
infect
almost
imposs
detect
plasma
donor
iatrogen
transmiss
prion
occur
patient
receiv
humanderiv
pituitari
hormon
human
growth
hormon
hgh
gonadotropin
cjd
transmit
recipi
cadaver
pituitari
hgh
withdraw
cadaver
pituitaryderiv
gonadotropin
infertil
associ
iatrogen
transmiss
cjd
later
cadaver
pituitari
hgh
gonadotropin
replac
recombin
gh
produc
microbi
system
recombin
gonadotropin
produc
cho
cell
line
nowaday
plant
system
effi
cientli
engin
produc
human
growth
hormon
human
serum
albumin
erythropoietin
antibodi
scfv
toxin
subunit
vaccin
insulin
increas
demand
consum
compani
tri
increas
product
challeng
largescal
product
protein
transgen
express
construct
chimer
structur
surround
variou
activ
regulatori
element
polyadenyl
site
play
import
role
high
level
express
transgen
caulifl
ower
mosaic
viru
camv
promot
work
well
dicot
strong
constitut
promot
made
activ
duplic
enhanc
region
howev
monocot
maiz
promot
prefer
promot
presenc
intron
region
enhanc
transcript
monocot
obtain
high
yield
protein
sever
factor
may
appropri
consid
incorpor
polyadenyl
site
may
camv
transcript
agrobacterium
tumefacien
no
gene
pea
ssu
gene
yield
control
place
gene
control
promot
activ
particular
tissu
development
stage
particular
environ
eg
rice
glutelin
pea
legumin
usag
induc
promot
eg
tomato
coa
mechan
gene
activ
system
develop
cramer
crop
tech
corp
virginia
usa
transcript
start
harvest
tobacco
leav
shear
process
codon
bia
host
plant
may
overcom
engin
transgen
posit
might
lead
truncat
andor
misincorpor
slow
process
subcellular
target
also
import
factor
affect
process
fold
assembl
posttransl
modifi
cation
effi
cientli
achiev
inclus
ntermin
signal
peptid
posit
transgen
integr
structur
transgen
locu
gene
copi
number
presenc
truncat
rearrang
transgen
copi
affi
niti
tag
flag
epitop
use
eas
process
purifi
cation
howev
modifi
cation
affect
primari
structur
also
properti
protein
figur
show
gener
vector
pcambia
small
size
kb
maintain
high
copi
number
replicon
impart
chloramphenicol
kanamycin
resist
high
stabil
agrobacterium
use
transgen
express
plant
modifi
ed
vector
shown
success
insulin
product
continu
challeng
product
therapeut
protein
import
gene
interest
give
adequ
protein
product
howev
express
may
lost
due
mani
factor
like
structur
chang
recombin
gene
inactiv
disappear
gene
host
cell
factor
infl
uenc
yield
may
increas
copi
number
insert
mainten
optimum
temperatur
toxic
express
protein
host
chromosom
integr
foreign
gene
might
overcom
problem
express
stabil
plasmid
base
system
high
copi
number
lead
increas
yield
posttransl
process
protein
fold
requir
foldas
acceler
protein
fold
chaperon
prevent
protein
format
nonn
insolubl
fold
intermedi
glycosyl
complex
ptm
requir
consecut
step
enzym
glycosyl
import
determin
protein
stabil
solubl
antigen
fold
local
biolog
activ
circul
halflif
get
correctli
glycosyl
fold
protein
requir
therapeut
usag
prokaryot
discoveri
nglycosyl
system
campylobact
jejuni
sever
system
oglycosyl
unravel
pathogen
symbiot
bacteria
product
recombin
protein
commonli
done
use
e
coli
yeast
cell
line
deriv
insect
mice
cho
obtain
fulli
human
ptm
challeng
task
fig
fi
gure
show
structur
pcambia
vector
cambiaorg
use
plant
transform
vector
promot
multipl
clone
site
report
gene
gu
gfp
may
use
vector
modifi
ed
express
gene
insulin
tomato
hepb
surfac
antigen
hbsag
recombin
therapeut
provid
human
glycosyl
pattern
increas
attent
effort
made
develop
novel
glycoengin
cell
line
product
fulli
glycosyl
protein
therapeut
overexpress
therapeut
protein
might
result
format
inclus
bodi
prokaryot
system
rapid
intracellular
protein
accumul
express
larg
protein
increas
probabl
aggreg
aggreg
protect
protein
proteolysi
facilit
protein
recoveri
express
protein
toxic
host
presenc
protein
inclus
bodi
tend
protect
precaut
recombin
protein
product
requir
precaut
result
loss
yield
andor
product
contamin
stage
contamin
might
occur
sourc
pose
big
challeng
may
advers
contamin
materi
put
human
usag
immun
respons
therapeut
agent
bodi
mount
immun
reaction
lead
deposit
immun
complex
variou
tissu
condit
anaphylact
shock
might
occur
eg
essenti
agent
lost
sinc
birth
like
factor
viii
patient
might
rais
antibodi
respons
treatment
also
occur
antibodi
use
therapeut
agent
treatment
varieti
cancer
protein
aggreg
nonfunct
condit
might
result
aggreg
loss
activ
recombin
protein
purifi
cation
proper
modifi
cation
refold
requir
therapeut
disulfi
de
bond
format
stabil
protein
structur
thu
strategi
specifi
c
extracellular
excret
pathway
overexpress
chaperon
requir
optimum
product
degrad
sometim
protein
activ
host
cell
like
proteas
proteinmodifi
chemic
might
degrad
recombin
protein
eg
peg
interferon
modifi
ed
polyethylen
glycol
prolong
presenc
reduct
enzymat
degrad
renal
clearanc
thu
extend
presenc
lesser
immunogen
ischem
stroke
myocardi
infarct
one
lead
caus
cardiovascular
morbid
mortal
world
import
thrombolyt
agent
urokinas
obtain
urin
tissu
plasminogen
activ
tpa
streptokinas
obtain
bacteria
among
tpa
larg
use
commerci
plasminogen
activ
serin
proteas
respons
convers
inact
proenzym
plasminogen
plga
singl
chain
glycoprotein
serin
proteas
call
plasmin
plm
plasmin
degrad
network
fi
brin
blood
clot
fig
two
immunolog
unrel
group
plasminogen
activ
kda
urokinasetypepa
upa
kda
tissuetyp
pa
tpa
ec
tpa
physiolog
vascular
activ
consist
singl
polypeptid
chain
kda
consist
amino
acid
show
strong
activ
presenc
fi
brin
potenti
inhibitor
thrombolyt
cascad
type
plasminogen
activ
inhibitor
serpin
secret
placenta
present
signifi
cant
amount
pregnanc
act
compet
tpa
bind
site
fi
brin
thu
prevent
fi
brinolyt
cascad
complex
tpa
bind
fi
brin
thu
truncat
tpa
residu
respons
interact
replac
four
alanin
amino
acid
three
domain
fi
nger
epiderm
growth
factor
egf
kringl
domain
delet
chimer
tetrapeptid
glyhisargpro
ghrp
high
affi
niti
fi
brin
ad
reteplas
delet
mutant
prolong
halflif
fi
nger
egf
kringl
domain
fulllength
molecul
delet
thu
inhibit
defi
cienci
pai
lead
fi
brinolysi
hemorrhag
diathesi
like
defi
cienci
clot
factor
tiplaxtinin
inhibitor
use
remodel
blood
vessel
plasminogen
activ
great
clinic
relev
manag
stroke
myocardi
infarct
product
tpa
e
coli
yeast
system
work
properli
due
lack
posttransl
modifi
cation
glycosyl
respect
novel
truncat
form
tpa
improv
fi
brin
affi
niti
increas
resist
express
cho
express
system
therapeut
protein
produc
stabli
transfect
cho
cell
line
cell
line
maintain
serumfre
medium
glutamin
hypoxanthin
thymin
stir
tank
bioreactor
cell
grown
rpm
co
humid
protein
purifi
ed
higher
yield
fig
factor
viii
one
import
factor
blood
clot
factor
defi
cienci
factor
viii
caus
bleed
disord
call
hemophilia
hemophilia
may
mild
sever
depend
ing
upon
factor
viii
concentr
bodi
moder
sever
factor
viii
defi
cienci
spontan
bleed
episod
joint
hemophilia
affect
male
replac
therapi
treatment
option
hemophiliac
either
human
plasmaderiv
factor
viii
pdfviii
recombin
fviii
rfviii
transfect
hek
cell
cultur
serumfre
suspens
tri
optim
yield
recombin
factor
viii
rfviii
produc
cultur
mammalian
cell
babi
hamster
kidney
bhk
chines
hamster
ovari
cell
cho
use
largescal
bioreactor
standard
done
maxim
yield
insulin
peptid
hormon
consist
amino
acid
secret
cell
islet
langerhan
pancrea
hormon
respons
maintain
normal
blood
glucos
level
blood
insulin
store
form
proinsulin
contain
two
polypeptid
chain
b
connect
third
peptid
cchain
secret
cleav
product
insulin
cchain
cleavag
result
remov
cchain
amino
acid
b
chain
amino
acid
link
disulfi
de
linkag
form
matur
insulin
begin
effort
made
isol
mrna
preand
proinsulin
rat
islet
langerhan
pancrea
synthes
cdna
thereaft
insert
plasmid
recombin
plasmid
transfer
e
coli
cell
secret
proinsulin
scientist
chemic
synthes
dna
sequenc
two
chain
b
insulin
separ
insert
two
plasmid
side
gene
recombin
plasmid
separ
transfer
e
coli
cell
secret
fuse
chain
chain
separ
chain
isol
pure
form
detach
yield
g
healthi
transform
cell
product
recombin
insulin
shown
fig
b
growth
hormon
produc
anterior
lobe
pituitari
gland
releas
multipl
puls
hgh
encod
ghn
gene
cluster
array
fi
close
relat
gene
local
chromosom
belong
divers
gene
famili
evolv
gene
duplic
event
lot
structur
similar
common
function
variou
form
predomin
form
hgh
kda
protein
amino
acid
two
disulfi
de
bond
gh
control
function
directli
act
certain
hormon
somatomedin
activ
exampl
insulinlik
growth
factor
wide
spectrum
role
play
promot
long
bone
growth
promot
normal
sex
organ
develop
puberti
regul
metabol
stimul
tissu
growth
repair
anabolicanticatabol
effect
via
improv
nitrogen
retent
modul
bone
miner
densiti
metabol
throughout
life
prolifer
cell
type
immun
system
appetit
stimul
breakdown
fat
lipolysi
clinic
condit
therapi
growth
hormon
given
treatment
dwarfi
sm
bone
fractur
skin
burn
bleed
ulcer
aid
recombin
human
growth
hormon
rhgh
kda
consist
long
chain
amino
acid
use
defi
cienci
disord
growth
hormon
children
use
growth
abnorm
short
statur
use
chronic
renal
insuffi
cienci
therapi
growth
hormon
also
approv
adult
growth
hormon
defi
cienci
gh
one
wide
use
hormon
estim
market
billion
usd
long
experi
administr
proven
therapi
safe
effect
variou
condit
growth
abnorm
earlier
pituitaryderiv
hgh
use
later
prohibit
found
associ
creutzfeldtjakob
diseas
recombin
dna
technolog
safe
abund
recombin
hgh
produc
variou
heterolog
system
nonglycosyl
human
growth
hormon
biolog
activ
thu
prefer
system
product
e
coli
allow
rapid
econom
product
larg
amount
recombin
hgh
rhgh
use
treat
ghdefi
cient
ghd
shortstatur
children
acceler
wound
heal
increas
insulinlik
growth
factor
igf
level
rhgh
increas
osteocalcin
type
procollagen
propeptid
picp
bone
densiti
administ
children
ghd
optim
product
strong
induc
promot
prefer
ipl
ipr
trc
e
coli
advantag
drive
overproduct
recombin
protein
apart
e
coli
human
somatotropin
hst
express
tri
biolog
activ
disulfi
debond
form
tobacco
chloroplast
hormon
use
treatment
hypopituitari
dwarfi
sm
children
addit
indic
treatment
turner
syndrom
chronic
renal
failur
hiv
wast
syndrom
possibl
treatment
elderli
growth
hormon
defi
cienci
human
occur
children
adult
hematopoiet
growth
factor
consist
cytokin
protein
hormon
produc
bodi
govern
product
matur
variou
cell
produc
process
hematopoiesi
bone
marrow
hematopoiet
stem
cell
precursor
cell
presenc
particular
growth
factor
differenti
becom
special
kind
cell
monocyt
macrophag
lymphocyt
red
blood
cell
one
import
growth
factor
erythropoietin
protein
hormon
produc
specifi
c
type
cell
kidney
presenc
erythropoietin
progenitor
cell
stimul
bone
marrow
form
matur
erythrocyt
red
blood
cell
thu
patient
chronic
kidney
diseas
unabl
maintain
adequ
amount
erythropoietin
normal
develop
erythrocyt
blood
result
low
number
red
blood
cell
subsequ
anemia
patient
either
requir
blood
transfus
erythropoietin
outsid
suppli
limit
natur
sourc
kidney
cell
thu
recombin
human
erythropoietin
amgen
trade
name
epoetin
alfa
market
anem
condit
involv
erythropoietin
human
gene
encod
erythropoietin
clone
chines
hamster
ovari
cell
line
product
human
protein
cell
line
continu
use
today
product
halflif
erythropoietin
increas
incorpor
glycosyl
protein
growth
factor
thu
analog
engin
two
extra
amino
acid
substrat
glycosyl
thu
product
done
cho
cell
line
product
fi
nlink
sugar
chain
almost
three
time
longer
life
erythropoietin
pdgf
regul
cell
growth
divis
play
signifi
cant
role
blood
vessel
format
angiogenesi
growth
blood
vessel
alreadi
exist
blood
vessel
tissu
may
act
autocrin
paracrin
stimul
cell
growth
vivo
pdgf
play
role
develop
cell
prolifer
cell
migrat
angiogenesi
link
atherosclerosi
fi
brosi
malign
diseas
pdgf
fi
differ
isoform
pdgfa
pdgfb
pdgfc
pdgfd
ab
heterodim
pdgfa
pdgfb
similar
amino
acid
sequenc
experi
suggest
differ
biolog
function
two
chain
differ
locat
differ
transcript
control
pgdfaa
releas
medium
pdgfbb
insuffi
cientli
secret
remain
attach
plasma
membran
pgdfbb
pdgfab
strong
mitogen
probabl
respons
biolog
role
pdgf
pdgf
receptor
pdgfr
receptor
tyrosin
kinas
rtk
alpha
beta
type
upon
activ
pdgf
receptor
dimer
lead
autophosphoryl
sever
site
cytosol
domain
pdgf
mitogen
promot
prolifer
fi
broblast
smooth
muscl
cell
vitro
pdgf
show
consider
heterogen
size
kda
howev
purifi
ed
pdgf
cation
protein
kda
recombin
human
plateletderiv
growth
factor
rhpdgf
fi
rst
recombin
protein
approv
us
food
drug
administr
treatment
chronic
foot
ulcer
diabet
patient
regranex
ethicon
inc
somervil
nj
potenti
use
bone
regener
increas
bone
densiti
long
bone
spine
pdgf
commerci
produc
use
e
coli
mammalian
cell
human
egf
protein
three
intracellular
disulfi
de
bond
play
import
role
regul
cell
growth
prolifer
show
strong
sequenti
function
homolog
human
typealpha
transform
growth
factor
htgf
alpha
competitor
egf
receptor
site
egf
act
bind
high
affi
niti
egfr
cell
surfac
stimul
intrins
protein
tyrosin
kinas
activ
egf
mani
biolog
activ
initi
observ
center
around
prolif
effect
fi
broblast
keratinocyt
epitheli
cell
egf
modul
lutein
hormon
thyroid
hormon
egf
produc
commerci
engin
e
coli
system
also
explor
optimum
egf
product
fgf
commonli
mitogen
multifunct
protein
wide
varieti
regulatori
morpholog
endocrin
effect
mammalian
fgf
affect
growth
function
wide
varieti
mesenchym
endocrin
nerv
cell
function
fgf
development
process
includ
mesoderm
induct
anteroposterior
pattern
limb
format
neural
tube
induct
brain
develop
matur
tissuesystem
angiogenesi
keratinocyt
organ
wound
heal
process
fgf
import
normal
develop
vertebr
invertebr
irregular
function
lead
rang
development
defect
show
strong
angiogen
properti
promot
endotheli
cell
prolifer
physic
organ
endotheli
cell
tubelik
structur
growth
new
blood
vessel
preexist
vasculatur
also
known
keratinocyt
growth
factor
kgf
respect
stimul
repair
injur
skin
mucos
tissu
stimul
prolifer
migrat
differenti
epitheli
cell
direct
chemotact
effect
tissu
remodel
fgf
secret
protein
bind
heparan
sulfat
therefor
caught
extracellular
matrix
tissu
contain
heparan
sulfat
proteoglycan
allow
act
local
paracrin
fashion
howev
subfamili
includ
bind
less
tightli
heparan
sulfat
act
endocrin
fashion
far
away
tissu
intestin
liver
kidney
adipos
bone
exampl
produc
intestin
cell
act
liver
cell
downregul
key
gene
bile
acid
synthas
pathway
produc
bone
act
kidney
cell
regul
synthesi
vitamin
turn
affect
calcium
homeostasi
fgf
may
synthes
use
e
coli
host
system
fgf
involv
stimul
collater
vascular
recoveri
ischemia
well
enhanc
wound
heal
nerv
regener
repair
cartilag
altern
refer
pluripot
capabl
develop
one
cell
type
tissu
growth
factor
promiscu
biochemistri
pharmacolog
concept
varieti
molecul
bind
elicit
respons
singl
receptor
growth
factor
due
multipl
action
multipl
cell
type
fgf
smallmolecul
fgf
receptor
kinas
inhibitor
use
treatment
cancer
cardiovascular
diseas
potenti
treatment
metabol
syndrom
hypophosphatem
diseas
receptor
tyrosin
kinas
inhibitor
sunitinib
approv
indic
renal
cell
carcinoma
gastrointestin
stromal
tumor
small
fgfr
inhibitor
nordihydroguaiaret
acid
effect
multipl
myeloma
cell
line
induc
cell
cycl
arrest
endometri
cancer
cell
mutat
antibodi
shown
effect
caus
apoptosi
mous
model
multipl
myeloma
bladder
cancer
thu
fgfr
inhibit
effect
treatment
cancer
nerv
growth
factor
ngf
import
member
famili
neurotrophin
five
protein
nerv
growth
factor
neurotrophin
famili
import
regul
develop
nervou
system
play
import
role
maintain
structur
plastic
repair
adult
nervou
system
neurotrophin
basic
protein
share
sequenc
homolog
highli
conserv
mammalian
speci
nerv
growth
factor
ngf
small
secret
protein
induc
differenti
surviv
particular
target
neuron
nerv
cell
littl
known
biolog
action
neurotrophin
apart
ngf
nucleotid
sequenc
cdna
predict
ngf
synthes
preprongf
upon
remov
hydrophob
signal
either
kda
kda
prongf
gener
depend
size
transcript
howev
process
precursor
differ
tissu
well
understood
essenti
normal
develop
growth
differenti
sympathet
sensori
neuron
also
essenti
maintain
normal
function
cell
adult
thu
import
matur
surviv
neuron
prevent
degener
adult
neuron
apart
import
role
nervou
system
shown
possess
protect
action
human
pressur
ulcer
corneal
ulcer
glaucoma
reduc
sensat
may
observ
leprosi
wound
heal
nerv
injuri
diabet
ngf
may
help
regul
sensori
fi
ber
sensit
function
directli
indirectli
stimul
effector
administr
recombin
ngf
may
improv
sensat
pain
cholinerg
neuron
basal
forebrain
show
receptor
ngf
specifi
c
mrna
variou
ngf
identifi
ed
differ
area
brain
cholinerg
neuron
loss
cardin
featur
alzheim
diseas
nerv
growth
factor
ngf
stimul
cholinerg
function
improv
memori
prevent
cholinerg
degener
anim
model
injuri
amyloid
overexpress
age
ngf
act
intracellular
calcium
tyrosin
kinas
receptor
mechan
nerv
growth
factor
enhanc
earli
regener
sever
exon
also
import
maintain
biochem
morpholog
phenotyp
matur
basal
forebrain
cholinerg
neuron
bfcnl
lesion
injuri
central
nervou
system
cn
thu
ngf
may
provid
therapeut
option
prevent
death
cholinerg
neuron
clinic
condit
produc
use
e
coli
exert
function
autocrin
endocrin
fashion
variou
cell
type
ectoderm
origin
includ
epitheli
cell
normal
transmembran
protein
function
cell
commun
abil
activ
receptor
tyrosin
kinas
ectodomain
cleav
highli
regul
manner
releas
solubl
activ
paracrin
signal
receptor
egftgf
alpha
receptor
therefor
focu
understand
import
role
egf
receptor
signal
carcinoma
develop
larg
group
relat
protein
famili
member
includ
bone
morphogenet
protein
bmp
growth
differenti
factor
gdp
affect
tissu
remodel
wound
repair
hematopoiesi
morphogenesi
embryon
develop
adult
stem
cell
differenti
immun
regul
switch
factor
iga
infl
ammat
exist
multipl
form
act
transmembran
serin
threonin
receptor
kinas
lead
activ
smad
act
tumor
suppressor
cancer
initi
promot
tumor
progress
role
control
embryon
develop
cellular
differenti
hormon
secret
immun
function
role
mesenchym
differenti
factor
focu
muscl
fat
bone
cell
might
provid
insight
deregul
skelet
development
diseas
area
activ
research
produc
use
cho
cell
line
huge
potenti
futur
therapi
use
protein
therapeut
agent
recombin
protein
benefi
cial
research
engin
improv
activ
prolong
stay
bodi
exampl
engin
monoclon
antibodi
toxin
radioisotop
gener
bispecifi
c
antibodi
still
technolog
struggl
hard
make
diseas
complet
text
book
societi
free
diseas
pathogen
product
protein
therapeut
purpos
import
specifi
c
action
minimum
side
effect
also
due
uniqu
form
function
nowaday
therapeut
pancreat
enzym
hog
pig
pancrea
inhibitor
pool
human
plasma
extract
nativ
sourc
human
anim
due
risk
transmiss
pathogen
problem
face
extract
nativ
sourc
scarc
avail
anim
tissu
product
high
cost
purifi
cation
less
yield
immunolog
reaction
recipi
major
biolog
therapeut
agent
produc
use
variou
advanc
tool
technolog
clone
select
purif
stabil
monitor
also
import
monitor
risk
side
effect
therapeut
safeti
analysi
obtain
wide
rang
cell
variou
biolog
system
avail
product
recombin
protein
bacteria
fungal
system
yeast
insect
cell
mammalian
cell
human
cell
transgen
plant
anim
system
choic
depend
upon
total
cost
product
obtain
fulli
function
appropri
modifi
ed
ptm
glycosyl
phosphoryl
properli
fold
protein
essenti
biolog
activ
protein
bacteri
system
simplest
short
cell
divis
time
easi
mainten
easi
modifi
costeffect
product
bacteria
limit
product
c
growth
factor
requir
progress
tumor
darbepoetin
use
treatment
